The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential Abilify lawsuits on behalf of children through the United States diagnosed with Type II diabetes after being prescribed the popular atypical antipsychotic medication.
Side effects of all atypical antipsychotics have been linked to a risk of diabetes. However, children using Abilify may face a particularly high risk, which was not adequately disclosed on the drug warning label.
As a result of childhood diabetes from Abilify, young users of the medication may face a lifetime of health problems and complications associated with the disease, including:
- Heart and Blood Vessel Disease
- Kidney Damage
- Nerve Damage
- Foot Injury or Amputation Risk
- Alzheimer’s Disease
- Eye Problems
- Hearing Impairment
- Skin Problems
- Sexual Dysfunction
- Pregnancy Complications
- Premature Death
Free Consultations with Abilify Lawyers
Abilify (aripiprazole) is one of the most widely used atypical antipschotic medications on the market. It has been aggressively marketed for use among children to treat a number of conditions, including schizophrenia, autism, bipolar disorder, behavioral problems and depression.
The drug makers have developed a blockbuster medication with over $6 billion in annual sales, in part based on a decision to withhold important safety information about the side effects of Abilify, including the risk of childhood diabetes.
The Abilify lawyers at Saiontz & Kirk, P.A. are providing free consultations and case evaluations to help families determine whether financial compensation may be available through a childhood diabetes lawsuit. As a result of the drug makers’ failure to adequately warn families and the medical community about the potential Abilify risks, children may face a lifetime of serious health problems associated with diabetes.
All cases are reviewed and handled by our law firm under a contingency fee agreement, which means that there are no out-of-pocket expenses to hire our lawyers and we receive no attorneys fees or reimbursement of expenses unless a recovery is obtained for an injury associated with the use of Abilify.